ROLR vs IVF
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 25, 2026
ROLR
IVF
Investment Advisor Scores
IVF
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ROLR | IVF | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -51.6% | 16.7% | IVF |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 48.4/100 | 48.4/100 | Tie |
| Profit Margin | 10.8% | -92.3% | ROLR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ROLR
MarkdownPrice below a falling SMA50 (slope -2.9%), weak momentum, RSI 28
IVF
MarkdownPrice below a falling SMA50 (slope -13.8%), weak momentum, RSI 34
Fundamentals Snapshot
| Metric | ROLR | IVF |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -21.3 | -0.1 |
| Trailing P/E | 32.8 | 0.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.5% | 0.2% |
| Gross Margin | 0.6% | 0.4% |
| Operating Margin | -0.9% | -0.6% |
| EPS | 0.15 | 361.73 |
| Dividend Yield | — | — |